Chieti, Italy - A variant of the COX-2 gene has been found that is associated with a decreased risk of MI and stroke [1]. The authors of the study claim that a test for this polymorphism, which has ...

Genotype-stratified outcomes showed ApaI AA carriers had no benefit (HR 1.02), while ApaI AC/CC carriers had reduced diabetes ...

Despite global vaccination efforts, COVID-19 continues to pose significant risks, leading to severe complications and fatalities. These risks are driven by disrupted coagulation, impaired fibrinolysis ...

Genomic medicine leverages an individual’s genetic information to guide healthcare decisions, with drug-gene testing (also known as pharmacogenomics, or PGx) being a key application that personalizes ...

Genetic testing can help doctors diagnose some neurological disorders, such as Huntington’s disease. It can also provide insights into a person’s risk of future health conditions. Genetic testing ...

Medicare Part B covers various genetic tests for diagnosing genetic conditions, identifying cancer risks, and predicting medication responses if a doctor deems them medically necessary. The cost of ...

Demand for germline hereditary cancer genetic testing has increased because of reduced cost, gene discovery, expanding indications, and precision cancer therapies. The traditional model for germline ...

The future of personalized medicine is rapidly becoming a reality, powered by advances in genetic testing and healthcare. Once limited to research labs, genetic insights are now transforming how ...

If at least two of your close family members have had a brain aneurysm, genetic testing may help identify if you’re at risk. A brain aneurysm is a bulge in one of your brain’s blood vessels. The flow ...

Targeting men in the top 10% of genetic risk helped detect high-grade prostate cancer that conventional screening would miss, paving the way for more personalized and effective early detection ...